Back to AMLX

Amylyx Pharmaceuticals, Inc. 8-K

Accession 0001193125-23-164027

Filing information

CIK
0001658551
Report date
2023-06-08
Filing date
2023-06-09
Form
8-K
Primary document
d501159d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.